eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Vaccines

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 694 490
Fax: +44 (0)1276 698 460
WWW: http://www.novartis.com
Medical Information Direct Line: +44 (0)8457 451 500
Medical Information e-mail: service.uk@novartis.com
Medical Information Fax: +44 (0)1517 055 669

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 10/06/2010
SPC Rabipur

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01-Dec-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

- in section 2.......the correct symbol  is now used instead of the previos =
- in section 2 - a typo has been corrected in the word 'purified'
- in section 6.5, the English form of the words (polypropylene) and (polyethylene) are used instead of the previous versions
Updated on 09/05/2010 and displayed until 10/06/2010
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

- In section 4.8 (undesirable effects), a typographical error has now been corrected for the 'dizziness' category to correctly inlcude the frequencies for 'uncommon' as >1/1000, <1/100. Previoulsy one of the '>' symbols was incorrectly placed
This did not require a new 'date of revision of tex' (section 10)
Updated on 12/03/2010 and displayed until 09/05/2010
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 6.2 - Incompatibilities
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

- In section 1, the type of  product has been changed to ' rabies vaccine, inactivated'
- In section 6.2, the text has now changed to

In the absence of compatibility studies, Rabipur must not be mixed in the same syringe with other medicinal products. No interactions with concomitant administration of other vaccines have been reported.
- In section 10, the date of (partial) revision of the text has been updated to February 2009

Updated on 18/02/2008 and displayed until 12/03/2010
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5    the folloiwng added  "... syringe (polypropylen with polyethylen plunger)"
Updated on 31/08/2004 and displayed until 18/02/2008
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   rabies vaccine